Takeda Pharmaceutical (TAK) Notches Its Fourth 52-Week High in a Week
As seen on the 24/7 Wall St. homepage on October 26, 2026.
Takeda's ADRs just set a fresh 52-week high at $20.43, the fourth record in a week for the drugmaker.
Continue ReadingShow less
Takeda's American depositary receipts reached $20.43, the fourth 52-week high in a week. A streak like that points to sustained buying pressure.
The most recent leg of the climb has been particularly steep, with the stock pushing through $19 and then $20 in quick succession after trading in the mid-to-upper teens for much of the year.
Sponsored
The latest record clears the prior 52-week high set on October 22 by just 0.34%. Investors will be watching whether the ADRs can hold above $20 on any pullback.
Takeda trades in the United States as depositary receipts, with the underlying shares also accessible through TKPHF. The combination of a multi-week momentum streak and back-to-back record closes makes this one of the more notable moves in large-cap international pharma right now.